Taipei Exchange - Delayed Quote TWD

Winston Medical Supply Co., Ltd. (6817.TWO)

102.00
-1.00
(-0.97%)
At close: 11:35:19 AM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
695,077
695,077
709,074
606,517
536,526
Cost of Revenue
379,237
379,237
361,476
342,069
299,134
Gross Profit
315,840
315,840
347,598
264,448
237,392
Operating Expense
156,589
156,589
151,505
129,897
120,932
Operating Income
159,251
159,251
196,093
134,551
116,460
Net Non Operating Interest Income Expense
-1,171
-1,171
-1,528
-1,059
-1,672
Pretax Income
164,180
164,180
198,818
141,398
116,587
Tax Provision
32,587
32,587
40,063
30,137
24,457
Net Income Common Stockholders
131,593
131,593
158,755
111,261
92,130
Diluted NI Available to Com Stockholders
131,593
131,593
158,755
111,261
92,130
Basic EPS
7.15
--
8.62
6.04
5.04
Diluted EPS
7.12
--
8.58
6.01
4.99
Basic Average Shares
18,404.62
--
18,417.05
18,417
18,293
Diluted Average Shares
18,482.16
--
18,502.91
18,498
18,449
Total Expenses
535,826
535,826
512,981
471,966
420,066
Net Income from Continuing & Discontinued Operation
131,593
131,593
158,755
111,261
92,130
Normalized Income
131,589.79
131,589.79
158,748.61
110,228.63
93,058.51
Interest Income
--
--
--
398
166
Interest Expense
1,171
1,171
1,528
1,059
1,838
Net Interest Income
-1,171
-1,171
-1,528
-1,059
-1,672
EBIT
165,351
165,351
200,346
142,457
118,425
EBITDA
194,995
194,995
228,325
178,753
154,549
Reconciled Cost of Revenue
379,237
379,237
361,476
342,069
299,134
Reconciled Depreciation
29,644
29,644
27,979
36,296
36,124
Net Income from Continuing Operation Net Minority Interest
131,593
131,593
158,755
111,261
92,130
Total Unusual Items Excluding Goodwill
4
4
8
1,312
-1,175
Total Unusual Items
4
4
8
1,312
-1,175
Normalized EBITDA
194,991
194,991
228,317
177,441
155,724
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0.79
0.79
1.61
279.63
-246.49
12/31/2021 - 2/24/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6467.TWO TAHO Pharma
59.10
+3.50%
 
6539.TWO DV Biomed Co., Ltd.
81.00
+2.27%
 
4172.TWO InnoPharmax Inc.
17.55
-2.23%
 
4166.TWO Orient Pharma Co., Ltd.
33.45
+1.36%
 
6620.TWO Handa Pharmaceuticals, Inc.
80.20
+0.50%
 
6677.TWO Anxo Pharmaceutical Co., Ltd.
16.05
-1.23%
 
6483.TWO Original BioMedicals Co., Ltd.
12.05
+0.42%
 
6621.TWO UniPharma Co., Ltd.
14.50
-0.68%
 
6785.TWO Alar Pharmaceuticals Inc.
139.50
-2.45%
 
6932.TWO Mercury Biopharmaceutical Corporation
13.00
-0.38%